Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview
Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication.
The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
Key Territories | · The US
· Europe · New Zealand · China · South Korea |
Key Regulatory Paths | · 510(k)
· CE-IVD · TGA · NMPA · MDITAC |
Leading Companies | · 1Drop Diagnostics
· Bio-AMD Inc · BiOracle Ltd (Inactive) · Coris BioConcept · Cue Health Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Cardiac Markers Rapid Tests and POC Pipeline Market Segmentation by Territories
A few of the key territories for the cardiac markers rapid tests and POC pipeline market are the US, Europe, New Zealand, China, and South Korea. As of February 2024, the US accounted for the highest number of pipeline products.
Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Cardiac Markers Rapid Tests and POC Pipeline Market
Cardiac Markers Rapid Tests and POC Pipeline Market Segmentation by Regulatory Paths
The key regulatory paths in the cardiac markers rapid tests and POC pipeline products market are 510(k), CE-IVD, TGA, NMPA, and MDITAC. As of February 2024, 510(k) was the most followed pathway for pipeline products in the market.
Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Cardiac Markers Rapid Tests and POC Pipeline Market
Cardiac Markers Rapid Tests and POC Pipeline Market – Competitive Landscape
A few of the key companies associated with the cardiac markers rapid tests and POC pipeline market are 1Drop Diagnostics, Bio-AMD Inc., BiOracle Ltd (Inactive), Coris BioConcept, and Cue Health Inc., among others.
Bio-AMD Inc: Bio-AMD is headquartered in Daresbury, the UK. It is a medical diagnostic company that develops point of care (POC) medical diagnostic device business and offers bio-alternative medical devices. Bio-AMD offers a magnetic immunoassay detection system (MIDS) and multiple application diagnostic technology. It serves customers through distributors across the US.
Coris BioConcept (Coris): Coris is headquartered in Namur City, Namur, Belgium. It is a medical device company that develops, manufactures, and markets rapid diagnostic tests. The company develops antigen detection tests for gastric, enteric, and respiratory diseases as well as test kits for veterinary and molecular fields. Coris offers custom test development and contract manufacturing services. The company conducts research and development on molecular biology and immuno-assays developments.
Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Cardiac Markers Rapid Tests and POC Pipeline Market
Segments Covered in the Report
Cardiac Markers Rapid Tests and POC Pipeline Market Territories Outlook
- The US
- Europe
- New Zealand
- China
- South Korea
Cardiac Markers Rapid Tests and POC Pipeline Market Regulatory Paths Outlook
- 510(k)
- CE-IVD
- TGA
- NMPA
- MDITAC
Scope
This report provides:
- Extensive coverage of the Cardiac Markers Rapid Tests and POC under development.
- Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of Cardiac Markers Rapid Tests and POC and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of Cardiac Markers Rapid Tests and POC under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Bio-AMD Inc
BiOracle Ltd (Inactive)
Coris BioConcept
Cue Health Inc
Diazyme Laboratories Inc
Duke University
Dynasil Corporation of America
Eachy Biopharmaceuticals Ltd
Maxim Biomedical Inc
MiCo BioMed Co Ltd
MyMD Pharmaceuticals Inc
Nanomix Inc
Nanospot.ai Inc
Novartis AG
Ohmx Corp
Thermo Fisher Scientific Inc
ThreeFold Sensors (Inactive)
True Diagnostics Inc
Upstream Medical Technologies Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the cardiac markers rapid tests and POC pipeline market in February 2024?
As of February 2024, the US accounted for the highest number of pipeline products in the cardiac markers rapid tests and POC market.
-
Which was the most followed regulatory pathway in the cardiac markers rapid tests and POC pipeline market in February 2024?
As of February 2024, 510(k) was the most followed pathway for pipeline products in the cardiac markers rapid tests and POC market.
-
Which are the major companies operating in the cardiac markers rapid tests and POC pipeline market?
A few of the key companies associated with the cardiac markers rapid tests and POC pipeline market are 1Drop Diagnostics, Bio-AMD Inc., BiOracle Ltd (Inactive), Coris BioConcept, and Cue Health Inc., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.